All News

Feet, foot

Foot Pain Commonly Overlooked in RA

d MedPage Today

Foot pain is a common but underappreciated symptom of rheumatoid arthritis (RA) and can be associated with worse disease, European researchers found.

Read Article
gout podagra inflammed

Best Interventions for Gout Flares

d Jack Cush, MD

A recent metanalysis assessed the comparative efficacy of current first-line pharmacologic antiinflammatory interventions for gout flares and surmised that canakinumab and intravenous or intramuscular corticosteroids are superior to  nonsteroidal antiinflammatory drugs [NSAIDs].

Read Article
pill,ASA,colchcine,small

COLCORONA: Protective Effect of Colchicine in COVID-19

d Jack Cush, MD

Lancet Respiratory Medicine has reported the results of the COLCORONA trial, showing that in patients with PCR-confirmed COVID-19 infection, colchicine led to a significantly lower rate of death or hospital admission from COVID.

Read Article
Hands-Down Rheumatology - Whats your diagnosis - Erosive Hand OA or Psoriati https://t.co/abYqBNhFyX arthritis?

Links:

Dr. John Cush RheumNow ( View Tweet)

Starting Thursday we'll be covering EULAR. Tune in for coverage on KOL perspective highlights, clinical trial highlights and much more. https://t.co/L7ryiQ5HdV
Dr. John Cush RheumNow ( View Tweet)
RNL 2021 - ACR COVID Vaccine Guidance: Dr. Jeff Curtis https://t.co/nJgbwB1RdA https://t.co/0Jir2vtaFH

Links:

Dr. John Cush RheumNow ( View Tweet)
Hands-Down Rheumatology - Sarcoidosis usually presents as a monarthritis or oligoarthritis. Late sarcoid arthritis affects knees, ankles, fingers (dactylitis). Bony lesions show honeycomb trabecular pattern). https://t.co/lmXBbJz6ts

Links:

Dr. John Cush RheumNow ( View Tweet)

Top May Tweet: Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Mechanics hands - rough, thickened/caloused, cracks/fissures; seen in 20-70% of dermatomyositis; associated with the anti-synthetase syndrome, but also w/ lung dz and amyopathic DM https://t.co/bkCI3SUXNh https://t.co/jrOGkKAm9z

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Swollen Hands In Rheumatoid Arthritis - could be from synovitis, tenosynovitis, edema, effusion, bony hypertrophy, nodules, secondary OA. https://t.co/dRCMzgdHqf

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Erosive hand osteoarthritis (EHOA) affects 2.6% of knee OA pts (from Osteoarthritis Initiative) Risk factors - older [RR 0.76), female (RR=1.73), greater OA severity, and "thinner bones" https://t.co/3s8E4F6QDR

Links:

Dr. John Cush RheumNow ( View Tweet)

News: Triple DMARD Therapy Bested by Biologics in Swedish Registry The Swedish Register compared outcomes of 1502 RA patients initiating either biologics plus MTX or triple therapy and showed similar rates of sustained remission. https://t.co/7JJxGF1tHz https://t.co/ht6kAsJkb9

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Heart, Lung & Liver (5.28.2021) Dr Jack Cush reviews the news and journal reports from this past week on RheumNow. https://t.co/a9fvgaJVnQ https://t.co/r3nbf2Ftdb

Links:

Dr. John Cush RheumNow ( View Tweet)
News: EULAR Guidelines on Intraarticular Therapy EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force. https://t.co/Z6vC0x9zY1 https://t.co/gVCWMIJxtu

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of National inpatient sample database (2015 to 2017) showed the frequency of atrial fibrillation in rheumatic disease (RD) pts finding that AF frequency highest in gout followed by vasculitis, and PMR. RD Mortality was 2 fold higher with AF. https://t.co/enno6hrKOI

Links:

Dr. John Cush RheumNow ( View Tweet)

A trial of sarilumab in 431 hospitalized COVID-19 patients on supplemental oxygen, Compared to placebo, sarilumab did not improve COVID outcomes https://t.co/postv1eK3F

Links:

Dr. John Cush RheumNow ( View Tweet)

Kidney biopsies in patients with lupus – how early and how often? Dr. Fogo and Dr.Hogan explain why a kidney biopsy is critical for diagnosis and characterization of kidney involvement by SLE #SLEEducatorsNetwork. Sponsored by GSK US Medical Affairs https://t.co/ta3hliB9ls https://t.co/hJE6BNlNqk

Links:

Dr. John Cush RheumNow ( View Tweet)
Pirfenidone, studied in 127 pts w/ CVD/CTD ILD, fibrotic interstitial pneumonia, chr hypersensitivity pneumonitis, & asbestoslung fibrosis. Pirefenidone had significantly less FVC% decline compared with placebo (p=0·043) https://t.co/H1s6ut4NhG

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Samir V. Parikh from the #SLEEducatorsNetwork discusses the major treatment goals for lupus nephritis and the broader needs of the patient in this program- Defining Treatment Goals for Lupus Nephritis. Sponsored by GSK US Medical Affairs https://t.co/f2Y707H2kR https://t.co/4xMIBp2yEh

Links:

Dr. John Cush RheumNow ( View Tweet)
RNL 2021: Treatment Advances in SpA: Dr. Nigil Haroon Dr. Nigil Haroon presents Treatment Advances in SpA at RheumNow Live 2021. https://t.co/9ZA0loThx6

Links:

Dr. John Cush RheumNow ( View Tweet)

×